The trademark application LYZURTRO was filed by Johnson & Johnson, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 9, 2021, and it was registered by office on August 16, 2021 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 19, 2022.